Indiana Attorney General Todd Rokita filed a new lawsuit against Eli Lilly on December 31, 2025, alleging an insulin price-fixing scheme. The lawsuit claims Lilly conspired with pharmacy benefit managers to inflate insulin sticker prices through secret rebates. Rokita, who attempted amicable resolution for two years, seeks structural changes and damages for affected consumers. Eli Lilly stated it has taken industry-leading steps, including capping patient out-of-pocket costs at $35/month. (Sources: indianapublicradio.org, clintoncountydailynews.com)
Indiana Sues Eli Lilly Over Alleged Insulin Price-Fixing Scheme
LLY
Related News
LLY
Eli Lilly Price Target Raised by Daiwa Securities Amid Strong Performance
LLY
Eli Lilly Stock Declines Amid Broader Market Gains and Valuation Debates
LLY
Eli Lilly Combination Therapy Achieves Superior Skin Clearance and Weight Loss in Phase 3b Psoriasis Trial
LLY
Eli Lilly and CSL Ink Licensing Deal for Anti-Inflammatory Drug
LLY